FDFairDoctor.org
Home/Procedures/Injection Trastuzumab-dkst Biosimilar Ogivri 10 Mg
HCPCS Q5114Medical Service

Injection Trastuzumab-dkst Biosimilar Ogivri 10 Mg

Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg. Clinical pricing breakdown and utilization metrics across 7 practicing doctors nationwide.

$182.00
Peer Median Charge
Gross billed rate
$40.67
Standard Baseline
Customary allowable
4.5x
National Markup
Charge vs baseline
7
Active Physicians
Billing this code
Planning care or already received a bill for CPT Q5114?Calculate total facility bundle costs or generate an assertive dispute settlement offer.

Understanding This Medical Fee

Gross Charge vs Negotiated Payment: The median physician charge for this service is $182.00. However, insured patients almost never pay this full amount directly. Insurers negotiate rates down toward the $40.67 baseline.

Self-Pay & Uninsured Guidance: If you are paying without insurance or out-of-network, request a prompt-pay cash discount. Most medical practices are willing to settle self-pay bills near the customary baseline rate rather than the full gross charge.

Key Questions for Your Doctor's Billing Office:
  • "Does Dr. [Name] participate in my specific insurance plan network?"
  • "What is the total self-pay or cash rate for code Q5114 if paid upfront?"
  • "Are there separate facility, anesthesia, or pathology fees associated with this procedure?"